Principal Scientist
Celerion
Lincoln, Nebraska
Dr. Kuiyi Xing is a Principal Scientist with 34 years of laboratory experience specializing in Ligand-Binding Assay (LBA) method development at Celerion. An expert in bioanalytical assay development, Dr. Xing plays a key role in developing pharmacokinetics (PK), pharmacodynamics (PD) anti-drug antibodies (ADA), and neutralizing antibodies (NAb) assays. His work focuses on the design, development, and validation of analytical methods, primarily utilizing platforms such as ELISA, MSD, and Gyrolab. Dr. Xing has been instrumental in developing validated spreadsheets for immunogenicity assays and optimizing process flow for various method development and validation processes.
Disclosure information not submitted.
Practical Management of Conjugates for ADA and NAb Assays
Tuesday, November 11, 2025
3:15 PM - 3:30 PM CT